According to the developers, the effectiveness of the drug is 91.4%, from the severe course of the coronavirus - 100%. Mass vaccination of citizens is underway in Russia.
In Moscow, in contrast to many European megalopolises, where risk groups find it difficult to receive the necessary vaccine, even city dwellers without a fixed abode can be vaccinated.
A special point has been organized for them at the Elizaveta Glinka Center for Social Adaptation for Homeless Persons. According to the head of the organization Olga Pavlicheva, the institution can be vaccinated not only against COVID-19, but also against influenza. The homeless are also given the necessary medicines, and if a person needs serious medical intervention, he is admitted to a hospital.
Experts believe that in a pandemic, mass vaccination is the most effective method of protecting the population. The whole world is participating in the "vaccine race", but only a few countries are able to produce them on their own, and the process of organizing vaccination itself is complicated, no one is immune from mistakes.
A scientific article by scientists from the Gamaleya Institute, published in the leading medical journal The Lancet, confirms the quality of Sputnik V. The effectiveness of the drug is estimated at 91.6%.
“The development of the Sputnik V vaccine has been criticized for inappropriate haste, cutting corners and lack of transparency. But the result, which is reported here (in the article of The Lancet), is clear, and the scientific principle of vaccination has been demonstrated, which means that now another vaccine can join the fight to reduce the incidence of COVID-19, "he wrote about the Russian drug Professor of Virology Ian Jones from the University of Reading (UK) in the official commentary on the journal's website.